Smithtown Assisted Living
(516) 265-7793
PD-L1 Inhibitor Wins NSCLC Indication
(MedPage Today) -- Atezolizumab for postplatinum, non-EGFR, non-ALK tumors
via
PD-L1 Inhibitor Wins NSCLC Indication
by
Newer Post
Older Post
Home